Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maicol Bissaro

Showing results (11-20 of 21) with videos related to

Pageof 3
Sort By:
Chemmedchem|October 26, 2018
Targeting Protein Kinase CK1δ with Riluzole: Could It Be One of the Possible Missing Bricks to Interpret Its Effect in the Treatment of ALS from a Molecular Point of View?Maicol Bissaro, Stephanie Federico, Veronica Salmaso, et al.
Current Medicinal Chemistry|February 9, 2022
Computational Strategies to Identify New Drug Candidates against NeuroinflammationMatteo Pavan, Davide Bassani, Giovanni Bolcato, et al.
Chemmedchem|April 2, 2021
Inspecting the Mechanism of Fragment Hits Binding on SARS-CoV-2 M<sup>pro</sup> by Using Supervised Molecular Dynamics (SuMD) SimulationsMaicol Bissaro, Giovanni Bolcato, Matteo Pavan, et al.
International Journal of Molecular Sciences|September 28, 2021
A Computational Workflow for the Identification of Novel Fragments Acting as Inhibitors of the Activity of Protein Kinase CK1δGiovanni Bolcato, Eleonora Cescon, Matteo Pavan, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry|October 29, 2020
HT-SuMD: making molecular dynamics simulations suitable for fragment-based screening. A comparative study with NMRFrancesca Ferrari, Maicol Bissaro, Simone Fabbian, et al.
ACS Medicinal Chemistry Letters|June 20, 2020
Scaffold Repurposing of in-House Chemical Library toward the Identification of New Casein Kinase 1 δ InhibitorsEleonora Cescon, Giovanni Bolcato, Stephanie Federico, et al.
International Journal of Molecular Sciences|August 22, 2019
Deciphering the Molecular Recognition Mechanism of Multidrug Resistance <i>Staphylococcus aureus</i> NorA Efflux Pump Using a Supervised Molecular Dynamics ApproachDeborah Palazzotti, Maicol Bissaro, Giovanni Bolcato, et al.
International Journal of Cancer|May 15, 2021
On the mechanism of tumor cell entry of aloe-emodin, a natural compound endowed with anticancer activityTeresa Pecere, Eleonora Ponterio, Enzo Di Iorio, et al.
European Journal of Medicinal Chemistry|March 15, 2021
Developing novel classes of protein kinase CK1δ inhibitors by fusing [1,2,4]triazole with different bicyclic heteroaromatic systemsIlenia Grieco, Maicol Bissaro, Davide Benedetto Tiz, et al.
Chemmedchem|December 15, 2018
A Triazolotriazine-Based Dual GSK-3β/CK-1δ Ligand as a Potential Neuroprotective Agent Presenting Two Different Mechanisms of Enzymatic InhibitionSara Redenti, Irene Marcovich, Teresa De Vita, et al.
Pageof 3

Showing results (11-20 of 21) with videos related to

Sort By:
Pageof 3
Chemmedchem|October 26, 2018
Targeting Protein Kinase CK1δ with Riluzole: Could It Be One of the Possible Missing Bricks to Interpret Its Effect in the Treatment of ALS from a Molecular Point of View?Maicol Bissaro, Stephanie Federico, Veronica Salmaso, et al.
Current Medicinal Chemistry|February 9, 2022
Computational Strategies to Identify New Drug Candidates against NeuroinflammationMatteo Pavan, Davide Bassani, Giovanni Bolcato, et al.
Chemmedchem|April 2, 2021
Inspecting the Mechanism of Fragment Hits Binding on SARS-CoV-2 M<sup>pro</sup> by Using Supervised Molecular Dynamics (SuMD) SimulationsMaicol Bissaro, Giovanni Bolcato, Matteo Pavan, et al.
International Journal of Molecular Sciences|September 28, 2021
A Computational Workflow for the Identification of Novel Fragments Acting as Inhibitors of the Activity of Protein Kinase CK1δGiovanni Bolcato, Eleonora Cescon, Matteo Pavan, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry|October 29, 2020
HT-SuMD: making molecular dynamics simulations suitable for fragment-based screening. A comparative study with NMRFrancesca Ferrari, Maicol Bissaro, Simone Fabbian, et al.
ACS Medicinal Chemistry Letters|June 20, 2020
Scaffold Repurposing of in-House Chemical Library toward the Identification of New Casein Kinase 1 δ InhibitorsEleonora Cescon, Giovanni Bolcato, Stephanie Federico, et al.
International Journal of Molecular Sciences|August 22, 2019
Deciphering the Molecular Recognition Mechanism of Multidrug Resistance <i>Staphylococcus aureus</i> NorA Efflux Pump Using a Supervised Molecular Dynamics ApproachDeborah Palazzotti, Maicol Bissaro, Giovanni Bolcato, et al.
International Journal of Cancer|May 15, 2021
On the mechanism of tumor cell entry of aloe-emodin, a natural compound endowed with anticancer activityTeresa Pecere, Eleonora Ponterio, Enzo Di Iorio, et al.
European Journal of Medicinal Chemistry|March 15, 2021
Developing novel classes of protein kinase CK1δ inhibitors by fusing [1,2,4]triazole with different bicyclic heteroaromatic systemsIlenia Grieco, Maicol Bissaro, Davide Benedetto Tiz, et al.
Chemmedchem|December 15, 2018
A Triazolotriazine-Based Dual GSK-3β/CK-1δ Ligand as a Potential Neuroprotective Agent Presenting Two Different Mechanisms of Enzymatic InhibitionSara Redenti, Irene Marcovich, Teresa De Vita, et al.
Pageof 3